Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
1.08T
Market cap1.08T
Price-Earnings ratio
38.60
Price-Earnings ratio38.60
Dividend yield
0.59%
Dividend yield0.59%
Average volume
2.20M
Average volume2.20M
High today
$1,151.23
High today$1,151.23
Low today
$1,134.72
Low today$1,134.72
Open price
$1,139.57
Open price$1,139.57
Volume
395.34K
Volume395.34K
52 Week high
$1,292.65
52 Week high$1,292.65
52 Week low
$712.05
52 Week low$712.05

Stock Snapshot

Eli Lilly(LLY) stock is priced at $1,145.78, giving the company a market capitalization of 1.08T. It carries a P/E multiple of 38.60 and pays a dividend yield of 0.59%.

On 2026-09-16, Eli Lilly(LLY) stock traded between a low of $1,134.72 and a high of $1,151.23. Shares are currently priced at $1,145.78, which is +1.0% above the low and -0.5% below the high.

The Eli Lilly(LLY)'s current trading volume is 395.34K, compared to an average daily volume of 2.2M.

During the past year, Eli Lilly(LLY) stock moved between $712.05 at its lowest and $1,292.65 at its peak.

During the past year, Eli Lilly(LLY) stock moved between $712.05 at its lowest and $1,292.65 at its peak.

LLY News

Investor's Business Daily 12m
Arista Stock Holds Up Well Amid Weakness. Here's How To Capitalize.

These 7 Stocks Are Analyst Favorites For Magnificent Earnings Growth; Cloudflare Hits Buy Point 9/16/2026 Among the best stocks in earnings performance, highly...

Arista Stock Holds Up Well Amid Weakness. Here's How To Capitalize.
Benzinga 39m
Beyond Hype: Twist Bioscience Secures Data Pipeline Role In Eli Lilly TuneLab Ecosystem

Twist Bioscience Corporation (NASDAQ:TWST) on Wednesday announced an agreement with Lilly TuneLab, a collaborative AI/ML drug discovery platform created by Eli...

Beyond Hype: Twist Bioscience Secures Data Pipeline Role In Eli Lilly TuneLab Ecosystem
TipRanks 3h
Twist Bioscience enters agreement with Lilly TuneLab

Twist Bioscience Corporation (TWST) announced an agreement with Lilly TuneLab, a collaborative AI/ML drug discovery platform created by Eli Lilly and Company (L...

Analyst ratings

84%

of 32 ratings
Buy
84.4%
Hold
9.4%
Sell
6.3%

More LLY News

Simply Wall St 9h
Eli Lilly Backs Nucleic Acid Research In Nervous System Diseases

Eli Lilly (NYSE: LLY) has entered a research and collaboration agreement with QurCan Therapeutics focused on nucleic acid therapies. The partnership targets ce...

Eli Lilly Backs Nucleic Acid Research In Nervous System Diseases
Nasdaq 21h
Eli Lilly's Momentum Looks Unstoppable -- but 1 Factor Could Change Everything

Key Points Eli Lilly's breakthroughs in its core therapeutic area are driving excellent financial results. The company could hit significant headwinds if it e...

Eli Lilly's Momentum Looks Unstoppable -- but 1 Factor Could Change Everything
24/7 Wall St. 23h
Novo Nordisk Expands Obesity Drug to Children, But Market Hesitates on Adoption

Investing Novo Nordisk Expands Obesity Drug to Children, But Market Hesitates on Adoption A landmark trial just proved semaglutide can pull children as young as...

Novo Nordisk Expands Obesity Drug to Children, But Market Hesitates on Adoption
Nasdaq 24h
Broker Darlings of the Dow: Johnson & Johnson Ranks As a Top 15 Analyst Pick

A study of analyst recommendations at the major brokerages shows that Johnson & Johnson (Symbol: JNJ) is the #10 broker pick, on average, out of the 30 stocks m...

Broker Darlings of the Dow: Johnson & Johnson Ranks As a Top 15 Analyst Pick
Seeking Alpha 1d
Eli Lilly boosted to Buy at Berenberg as upside to 2026 guidance seen

Berenberg upgraded Eli Lilly (LLY) to Buy from Hold, saying that it sees the drugmaker exceeding its 2026 guidance driven by continuing its lead in the weight-l...

Eli Lilly boosted to Buy at Berenberg as upside to 2026 guidance seen
Benzinga 1d
Eli Lilly Stock Gains as Retatrutide and Foundayo Data Highlight Pipeline Strength

Shares of Eli Lilly and Company (NYSE:LLY) are trading higher Tuesday morning following positive previews of its late-stage obesity and diabetes pipeline. Eli...

Eli Lilly Stock Gains as Retatrutide and Foundayo Data Highlight Pipeline Strength
24/7 Wall St. 1d
There Are Plenty of Eli Lilly Bulls: Here's What They Aren't Telling You

Investing There Are Plenty of Eli Lilly Bulls: Here’s What They Aren’t Telling You Eli Lilly's bulls are pointing at a 47% revenue surge and a pipeline loaded w...

There Are Plenty of Eli Lilly Bulls: Here's What They Aren't Telling You

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.